| Primary |
| Hypertension |
38.2% |
| Product Used For Unknown Indication |
37.4% |
| Drug Use For Unknown Indication |
7.1% |
| Ill-defined Disorder |
1.8% |
| Blood Pressure |
1.5% |
| Overdose |
1.4% |
| Essential Hypertension |
1.4% |
| Angina Pectoris |
1.2% |
| Suicide Attempt |
1.2% |
| Hyperlipidaemia |
1.1% |
| Asthma |
1.0% |
| Cardiovascular Disorder |
0.9% |
| Intentional Overdose |
0.8% |
| Depression |
0.8% |
| Diabetes Mellitus |
0.8% |
| Blood Pressure Increased |
0.7% |
| Gastritis Prophylaxis |
0.7% |
| Pain |
0.7% |
| Blood Cholesterol Increased |
0.6% |
| Osteoporosis |
0.6% |
|
| Completed Suicide |
13.8% |
| Toxicity To Various Agents |
9.5% |
| Oedema Peripheral |
7.4% |
| Overdose |
7.2% |
| Vomiting |
5.9% |
| Parkinsonism |
5.3% |
| Headache |
4.5% |
| Syncope |
4.4% |
| Rash |
4.0% |
| Renal Failure Acute |
4.0% |
| Hypotension |
3.8% |
| Product Substitution Issue |
3.8% |
| Myalgia |
3.7% |
| Shock |
3.6% |
| Suicide Attempt |
3.6% |
| Drug Ineffective |
3.5% |
| Weight Decreased |
3.5% |
| Loss Of Consciousness |
3.2% |
| Therapeutic Response Unexpected With Drug Substitution |
2.8% |
| Vision Blurred |
2.7% |
|
| Secondary |
| Product Used For Unknown Indication |
34.0% |
| Hypertension |
29.5% |
| Drug Use For Unknown Indication |
12.9% |
| Cardiovascular Disorder |
2.6% |
| Drug Abuse |
2.6% |
| Type 2 Diabetes Mellitus |
1.9% |
| Diabetes Mellitus |
1.6% |
| Suicide Attempt |
1.4% |
| Rheumatoid Arthritis |
1.2% |
| Adult T-cell Lymphoma/leukaemia |
1.2% |
| Hyperlipidaemia |
1.2% |
| Angina Pectoris |
1.2% |
| Essential Hypertension |
1.2% |
| Depression |
1.2% |
| Overdose |
1.1% |
| Asthma |
1.1% |
| Coronary Artery Disease |
1.1% |
| Ill-defined Disorder |
1.0% |
| Pain |
1.0% |
| Arrhythmia |
0.9% |
|
| Completed Suicide |
23.6% |
| Toxicity To Various Agents |
10.9% |
| Syncope |
7.0% |
| Vomiting |
6.4% |
| Hypotension |
5.1% |
| Death |
4.5% |
| Overdose |
4.3% |
| Oedema Peripheral |
4.1% |
| Poisoning |
4.1% |
| Renal Failure Acute |
3.7% |
| Suicide Attempt |
3.2% |
| Weight Decreased |
3.2% |
| Renal Failure |
3.0% |
| Angioedema |
2.9% |
| Somnolence |
2.7% |
| Loss Of Consciousness |
2.4% |
| Respiratory Arrest |
2.3% |
| Dizziness |
2.2% |
| Drug Ineffective |
2.1% |
| Hypertension |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.7% |
| Hypertension |
22.1% |
| Drug Use For Unknown Indication |
15.4% |
| Rheumatoid Arthritis |
4.4% |
| Diabetes Mellitus |
3.5% |
| Prophylaxis |
3.4% |
| Pain |
2.8% |
| Blood Cholesterol Increased |
2.1% |
| Type 2 Diabetes Mellitus |
1.9% |
| Depression |
1.9% |
| Atrial Fibrillation |
1.8% |
| Osteoporosis |
1.5% |
| Blood Pressure |
1.4% |
| Multiple Myeloma |
1.3% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Hepatitis C |
1.2% |
| Insomnia |
1.0% |
| Hyperlipidaemia |
1.0% |
| Constipation |
1.0% |
|
| Vomiting |
13.5% |
| Weight Decreased |
8.2% |
| Renal Failure Acute |
7.1% |
| Pneumonia |
6.0% |
| Death |
5.6% |
| Nausea |
5.2% |
| Drug Ineffective |
4.7% |
| Urinary Tract Infection |
4.6% |
| Pyrexia |
4.3% |
| Renal Failure |
4.3% |
| Pruritus |
4.1% |
| Rash |
4.0% |
| Weight Increased |
3.9% |
| Dyspnoea |
3.7% |
| Pain |
3.6% |
| Flushing |
3.5% |
| Rhabdomyolysis |
3.5% |
| Renal Impairment |
3.4% |
| Vision Blurred |
3.4% |
| Sepsis |
3.4% |
|
| Interacting |
| Hypertension |
33.0% |
| Product Used For Unknown Indication |
20.1% |
| Drug Use For Unknown Indication |
11.8% |
| Hiv Infection |
5.0% |
| Disseminated Tuberculosis |
3.8% |
| Coronary Artery Disease |
3.0% |
| Blood Pressure Increased |
2.7% |
| Depression |
2.7% |
| Blood Pressure |
2.6% |
| Atrial Fibrillation |
2.0% |
| Blood Cholesterol Increased |
2.0% |
| Cerebrovascular Accident |
1.7% |
| Herpes Simplex |
1.7% |
| Blood Pressure Abnormal |
1.5% |
| Hyperlipidaemia |
1.4% |
| Hypercholesterolaemia |
1.2% |
| Diabetes Mellitus |
1.1% |
| Splenectomy |
1.1% |
| Arrhythmia |
0.9% |
| Cognitive Disorder |
0.9% |
|
| Toxicity To Various Agents |
16.5% |
| Drug Interaction |
13.4% |
| Oedema Peripheral |
8.7% |
| Renal Failure Acute |
7.9% |
| Syncope |
5.5% |
| White Blood Cell Count Increased |
5.5% |
| Rhabdomyolysis |
4.7% |
| Weight Increased |
4.7% |
| Product Quality Issue |
3.9% |
| Hypotension |
3.1% |
| Myalgia |
3.1% |
| Transaminases Increased |
3.1% |
| Vertigo |
3.1% |
| Dysarthria |
2.4% |
| Hepatitis Toxic |
2.4% |
| Hypertensive Encephalopathy |
2.4% |
| Peroneal Nerve Palsy |
2.4% |
| Potentiating Drug Interaction |
2.4% |
| Shock |
2.4% |
| Vomiting |
2.4% |
|
